A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to develop procedures for testing the effectiveness of curcumin on slowing Alzheimer's disease (AD) progression.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese University of Hong Kong
• Collaborators: BUPA Foundation; Kwong Wah Hospital
• Treatments: Curcumin

Criteria

Inclusion Criteria:

• Ethnic Chinese living in Hong Kong

• Progressive decline in memory and cognitive function for at least 6 months

• NINCDS-ADRDA diagnosis of possible or probable AD

• Mild to severe dementia with Cantonese version of MMSE scores between 0 and 28

• Informed consent from patient and/or caregiver

• Both elderly home residents and outpatients are eligible

• Patients may take any medication

Exclusion Criteria:

• Anticoagulant or antiplatelet treatment or bleeding risk factors

• Currently smoking

• Other severe, end-stage illness